CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 111888-112131 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"A similar reaction occurred following re-challenge with amprenavir alone (600 mg oral formulation BID via percutaneous endoscopic gastrostomy (PEG) tube), despite concurrent administration of oral prednisone 20 mg/day and loratidine 10 mg/day.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T47310","span":{"begin":0,"end":243},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T47310","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T200","span":{"begin":0,"end":243},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T200","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T142","span":{"begin":0,"end":243},"obj":"Sentence"}],"attributes":[{"subj":"T142","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T184","span":{"begin":148,"end":152},"obj":"Body_part"}],"attributes":[{"id":"A184","pred":"uberon_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/UBERON_0000025"},{"subj":"T184","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eca493","default":true},{"id":"Epistemic_Statements","color":"#939bec"},{"id":"CORD-19_Custom_license_subset","color":"#b5ec93"},{"id":"CORD-19-PD-UBERON","color":"#ec93cf"}]}]}}